BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35641240)

  • 1. GCKIII kinases in lipotoxicity: Roles in NAFLD and beyond.
    Mahlapuu M; Caputo M; Xia Y; Cansby E
    Hepatol Commun; 2022 Oct; 6(10):2613-2622. PubMed ID: 35641240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
    Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease.
    Caputo M; Kurhe Y; Kumari S; Cansby E; Amrutkar M; Scandalis E; Booten SL; Ståhlman M; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    FASEB J; 2021 May; 35(5):e21567. PubMed ID: 33891332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
    FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STK25 is a critical determinant in nonalcoholic steatohepatitis.
    Amrutkar M; Chursa U; Kern M; Nuñez-Durán E; Ståhlman M; Sütt S; Borén J; Johansson BR; Marschall HU; Blüher M; Mahlapuu M
    FASEB J; 2016 Oct; 30(10):3628-3643. PubMed ID: 27421788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STE20-type kinases MST3 and MST4 promote the progression of hepatocellular carcinoma: Evidence from human cell culture and expression profiling of liver biopsies.
    Caputo M; Xia Y; Anand SK; Cansby E; Andersson E; Marschall HU; Königsrainer A; Peter A; Mahlapuu M
    FASEB J; 2023 Aug; 37(8):e23105. PubMed ID: 37490000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans.
    Cansby E; Kulkarni NM; Magnusson E; Kurhe Y; Amrutkar M; Nerstedt A; Ståhlman M; Sihlbom C; Marschall HU; Borén J; Blüher M; Mahlapuu M
    FASEB J; 2019 Sep; 33(9):9974-9989. PubMed ID: 31173506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver.
    Nerstedt A; Kurhe Y; Cansby E; Caputo M; Gao L; Vorontsov E; Ståhlman M; Nuñez-Durán E; Borén J; Marschall HU; Mashek DG; Saunders DN; Sihlbom C; Hoy AJ; Mahlapuu M
    J Lipid Res; 2020 Feb; 61(2):178-191. PubMed ID: 31857389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STE20-type kinase TAOK3 regulates hepatic lipid partitioning.
    Xia Y; Caputo M; Cansby E; Anand SK; Sütt S; Henricsson M; Porosk R; Marschall HU; Blüher M; Mahlapuu M
    Mol Metab; 2021 Dec; 54():101353. PubMed ID: 34634521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
    Mashek DG
    Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STE20-Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes.
    Caputo M; Cansby E; Kumari S; Kurhe Y; Nair S; Ståhlman M; Kulkarni NM; Borén J; Marschall HU; Blüher M; Mahlapuu M
    Hepatol Commun; 2021 Jul; 5(7):1183-1200. PubMed ID: 34278168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damage.
    Anand SK; Caputo M; Xia Y; Andersson E; Cansby E; Kumari S; Henricsson M; Porosk R; Keuenhof KS; Höög JL; Nair S; Marschall HU; Blüher M; Mahlapuu M
    J Lipid Res; 2022 Jul; 63(7):100238. PubMed ID: 35679904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
    Cansby E; Magnusson E; Nuñez-Durán E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Ståhlman M; Howell BW; Marschall HU; Borén J; Mahlapuu M
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1723-1737. PubMed ID: 29930001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the Kinase Activity of GCKIII Proteins In Vitro.
    Zalvide J; Almengló C; Vázquez S; García-Colomer M; Sartages M; Pombo CM
    Methods Mol Biol; 2020; 2152():437-443. PubMed ID: 32524571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of STE20-type kinase TAOK1 confers protection against hepatocellular lipotoxicity through metabolic rewiring.
    Xia Y; Andersson E; Anand SK; Cansby E; Caputo M; Kumari S; Porosk R; Kilk K; Nair S; Marschall HU; Blüher M; Mahlapuu M
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36930872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonizing STK25 Signaling Suppresses the Development of Hepatocellular Carcinoma Through Targeting Metabolic, Inflammatory, and Pro-Oncogenic Pathways.
    Kurhe Y; Caputo M; Cansby E; Xia Y; Kumari S; Anand SK; Howell BW; Marschall HU; Mahlapuu M
    Cell Mol Gastroenterol Hepatol; 2022; 13(2):405-423. PubMed ID: 34624527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STK25 and MST3 Have Overlapping Roles to Regulate Rho GTPases during Cortical Development.
    Matsuki T; Iio A; Ueda M; Tsuneura Y; Howell BW; Nakayama A
    J Neurosci; 2021 Oct; 41(43):8887-8903. PubMed ID: 34518307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOcK, MiSTs, MASK and STicKs: the GCKIII (germinal centre kinase III) kinases and their heterologous protein-protein interactions.
    Sugden PH; McGuffin LJ; Clerk A
    Biochem J; 2013 Aug; 454(1):13-30. PubMed ID: 23889253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GCKIII (Germinal Center Kinase III) Kinases STK24 and STK25 (Serine/Threonine Kinase 24 and 25) Inhibit Cavernoma Development.
    Sartages M; García-Colomer M; Iglesias C; Howell BW; Macía M; Peña P; Pombo CM; Zalvide J
    Stroke; 2022 Mar; 53(3):976-986. PubMed ID: 35130716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
    Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
    J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.